In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients
about
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicityAntimicrobial susceptibility of coagulase-negative staphylococci.Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period.In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.Current perspectives on glycopeptide resistance.Antimicrobial activity of MDL 62,873, a semisynthetic derivative of teicoplanin, in vitro and in experimental infectionsIn vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic.Emergence of teicoplanin-resistant coagulase-negative staphylococciRandomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic responseA prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.Infections due to antibiotic-resistant gram-positive cocci.A closer look at vancomycin, teicoplanin, and antimicrobial resistance.Vancomycin-intermediate Staphylococcus epidermidis: curio or omen?A multicentre study: Staphylococcus and Enterococcus susceptibility to antibiotics.Activity of daptomycin against enterococci and coagulase-negative staphylococci (CNS): relationship between CNS susceptibility and slime production.
P2860
Q28326763-75F866BC-64A8-4D1F-9E8E-07D0B43B0B19Q33760227-1359BB1A-346C-4F88-8B59-63E556D65D57Q33966785-2B5813D8-5503-4FD5-90F0-F5B3C9CA9EF7Q35281149-99D34828-9DBD-4878-BC83-2DD6520788BCQ35368590-950E1B14-C5E8-4934-8A47-D75DC5126BFCQ35826240-7348765D-40EA-4BFE-A461-DC6FA425A540Q35846789-5369F91B-DFD5-4243-9528-A854D63D42D7Q36535437-5F198151-82F6-4F23-BA49-A8BFD35BEB7CQ36753066-06D70F14-B238-455E-8930-120C5E0BDBD2Q39881225-1CF02744-D7C7-48E1-8D0E-F60F1C690B58Q40755970-BE0A1C83-D164-47D0-A8AB-36984946C791Q40804876-834299E4-53BB-4BD0-9659-F69646206A8FQ41646436-B75A52B7-2DE9-4787-9C70-11231E64DDDAQ54101396-253EB913-4B7B-4550-A631-83729315C1A2Q54194033-9F97DB7F-31AF-451C-8BF5-557F5896D59BQ54238573-63E7A780-F0E4-4629-B6A5-667A93E150F1
P2860
In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
In vitro activities of vancomy ...... ated from neutropenic patients
@ast
In vitro activities of vancomy ...... ated from neutropenic patients
@en
type
label
In vitro activities of vancomy ...... ated from neutropenic patients
@ast
In vitro activities of vancomy ...... ated from neutropenic patients
@en
prefLabel
In vitro activities of vancomy ...... ated from neutropenic patients
@ast
In vitro activities of vancomy ...... ated from neutropenic patients
@en
P2093
P2860
P356
P1476
In vitro activities of vancomy ...... ated from neutropenic patients
@en
P2093
P2860
P304
P356
10.1128/AAC.34.5.901
P407
P577
1990-05-01T00:00:00Z